Abolfazl Fateh

3.0k total citations
163 papers, 2.2k citations indexed

About

Abolfazl Fateh is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Abolfazl Fateh has authored 163 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Infectious Diseases, 75 papers in Epidemiology and 50 papers in Molecular Biology. Recurrent topics in Abolfazl Fateh's work include Tuberculosis Research and Epidemiology (59 papers), Mycobacterium research and diagnosis (47 papers) and Gut microbiota and health (22 papers). Abolfazl Fateh is often cited by papers focused on Tuberculosis Research and Epidemiology (59 papers), Mycobacterium research and diagnosis (47 papers) and Gut microbiota and health (22 papers). Abolfazl Fateh collaborates with scholars based in Iran, Italy and United States. Abolfazl Fateh's co-authors include Seyed Davar Siadat, Farzam Vaziri, Fatemeh Rahimi Jamnani, Enayat Anvari, Samira Tarashi, Sara Ahmadi Badi, Fatemeh Sakhaee, Ava Behrouzi, Arfa Moshiri and Shohreh Khatami and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Abolfazl Fateh

151 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abolfazl Fateh Iran 23 928 881 698 264 197 163 2.2k
Farzam Vaziri Iran 28 1.4k 1.5× 773 0.9× 747 1.1× 444 1.7× 250 1.3× 143 2.6k
Rachel Williams United Kingdom 29 789 0.9× 952 1.1× 629 0.9× 217 0.8× 209 1.1× 70 2.3k
Michael S. Bronze United States 34 997 1.1× 710 0.8× 610 0.9× 401 1.5× 376 1.9× 90 3.4k
Hossein Bannazadeh Baghi Iran 33 954 1.0× 717 0.8× 657 0.9× 163 0.6× 355 1.8× 138 2.8k
Taylor S. Cohen United States 29 1.2k 1.3× 468 0.5× 646 0.9× 254 1.0× 865 4.4× 57 3.1k
Karin Allenspach United States 39 1.3k 1.4× 665 0.8× 441 0.6× 532 2.0× 635 3.2× 179 4.6k
Yoshio Mori Japan 30 816 0.9× 1.2k 1.4× 788 1.1× 308 1.2× 294 1.5× 176 3.5k
Tobias Tenenbaum Germany 31 406 0.4× 745 0.8× 900 1.3× 181 0.7× 498 2.5× 110 3.0k
Brian C. Keller United States 18 1.5k 1.6× 1.1k 1.3× 643 0.9× 236 0.9× 723 3.7× 48 3.4k
Jonathan L. Koff United States 23 959 1.0× 374 0.4× 407 0.6× 190 0.7× 578 2.9× 49 2.8k

Countries citing papers authored by Abolfazl Fateh

Since Specialization
Citations

This map shows the geographic impact of Abolfazl Fateh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abolfazl Fateh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abolfazl Fateh more than expected).

Fields of papers citing papers by Abolfazl Fateh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abolfazl Fateh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abolfazl Fateh. The network helps show where Abolfazl Fateh may publish in the future.

Co-authorship network of co-authors of Abolfazl Fateh

This figure shows the co-authorship network connecting the top 25 collaborators of Abolfazl Fateh. A scholar is included among the top collaborators of Abolfazl Fateh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abolfazl Fateh. Abolfazl Fateh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
4.
Naseri, Ardalan, et al.. (2025). Molecular prevalence and genotypic distribution of human pegivirus-1 among Iranian hemodialysis patients. Virus Research. 356. 199582–199582.
5.
Samieefar, Noosha, et al.. (2025). Tuberculosis Trends in the Post‐COVID‐19 Era: Is It Going to be a Global Concern?. Health Science Reports. 8(5). e70792–e70792.
7.
Anvari, Enayat, et al.. (2023). Association of ApaI rs7975232 and BsmI rs1544410 in clinical outcomes of COVID-19 patients according to different SARS-CoV-2 variants. Scientific Reports. 13(1). 3612–3612. 10 indexed citations
8.
Goodarzi, Mohammad Taghi, et al.. (2023). Relationship Between Human FC γ RIIA rs1801274 G Allele and Risk of Death Among Different SARS-CoV-2 Variants. Viral Immunology. 36(10). 678–685. 1 indexed citations
9.
Tarashi, Samira, Seyed Davar Siadat, & Abolfazl Fateh. (2022). Nontuberculous Mycobacterial Resistance to Antibiotics and Disinfectants: Challenges Still Ahead. BioMed Research International. 2022(1). 8168750–8168750. 22 indexed citations
10.
Sakhaee, Fatemeh, et al.. (2022). Angiotensin‐converting enzyme 2 rs2285666 polymorphism and clinical parameters as the determinants of COVID‐19 severity in Iranian population. International Journal of Immunogenetics. 49(5). 325–332. 24 indexed citations
11.
Sakhaee, Fatemeh, et al.. (2022). Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality. Cytokine. 157. 155957–155957. 19 indexed citations
12.
Tarashi, Samira, Mir Davood Omrani, Abolfazl Fateh, et al.. (2022). Commensal and Pathogenic Bacterial-Derived Extracellular Vesicles in Host-Bacterial and Interbacterial Dialogues: Two Sides of the Same Coin. Journal of Immunology Research. 2022. 1–15. 19 indexed citations
13.
Badi, Sara Ahmadi, Samira Tarashi, Abolfazl Fateh, et al.. (2021). From the Role of Microbiota in Gut‐Lung Axis to SARS‐CoV‐2 Pathogenesis. Mediators of Inflammation. 2021(1). 6611222–6611222. 26 indexed citations
14.
Ejtahed, Hanieh‐Sadat, Zahra Hoseini Tavassol, Ava Behrouzi, et al.. (2020). Main gut bacterial composition differs between patients with type 1 and type 2 diabetes and non-diabetic adults. Journal of Diabetes & Metabolic Disorders. 19(1). 265–271. 42 indexed citations
15.
Moshiri, Arfa, Majid Taati, Azadeh Ghaheri, et al.. (2020). The First Report of Differences in Gut Microbiota Composition between Obese and Normal Weight Iranian Subjects. Iranian Biomedical Journal. 24(3). 148–154. 20 indexed citations
16.
Fateh, Abolfazl, et al.. (2019). The effect of three hand disinfectants on Staphylococcus aureus resistant to methicillin in different periods of time. SHILAP Revista de lepidopterología.
17.
Davari, Mehdi D., Fatemeh Sakhaee, Farzam Vaziri, et al.. (2018). Genetic Diversity and Prevalence of Nontuberculous Mycobacteria Isolated from Clinical Samples in Tehran, Iran. Microbial Drug Resistance. 25(2). 264–270. 19 indexed citations
18.
Fateh, Abolfazl, Fatemeh Rahimi Jamnani, Ahmad Reza Bahrmand, et al.. (2016). High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country. Microbial Pathogenesis. 93. 213–218. 14 indexed citations
19.
Fateh, Abolfazl, et al.. (2011). Purification of modified mycobacterial A60 antigen by affinity chromatography and its use for rapid diagnostic tuberculosis infection. Journal of Microbiological Methods. 87(2). 184–188. 4 indexed citations
20.
Bostanabad, Saeed Zaker, et al.. (2007). Frequency and molecular characterization of rifampicin- resistance in rpoB region of multiple drug resistance (MDR) isolates from tuberculosis patients in southern endemic region of Iran. Iranian Journal of Biotechnology. 5(4). 212–218. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026